Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02250755 : MRI Perfusion on T1 and T2 Brain Lesion(s)
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Major Patients

- Addressed to MRI for initial assessment of brain metastases

- At a suspicion of one or more brain metastases in the brain scanner routine screening

- Followed for lung cancer histologically documented in the Thoracic Oncology Service
of Professor Lafitte (contact: Dr Cortot)

- To whom treatment with chemotherapy or targeted therapy (including anti-angiogenic)
is considered

- Be socially insured-

Exclusion Criteria:

- Absolute contraindication to MRI (pacemaker, implantable pacemaker, metallic foreign
body intraorbital)

- Patients minors under guardianship / curatorship

- Patients with impaired judgment skills or unable to receive information

- Pregnant Women

- Patients for which lesions are not compatible with lung metastases

- Patients with brain metastases or already known and explored MRI

- Patients for whom treatment by surgical excision of brain metastases is considered
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02250755      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740